Could Brazil become Mabwell’s next denosumab biosimilar market after ANVISA GMP inspection?
Mabwell clears ANVISA GMP inspection for 9MW0311 and 9MW0321, advancing its denosumab biosimilar registration strategy in Brazil.
Pharma & Biotech
Medical Devices & Diagnostics
Butterfly Network enters Brazil with iQ+ and iQ3 handheld ultrasound systems
Discover how Butterfly Network’s Brazil launch could reshape point-of-care ultrasound access, adoption and competition across Latin America.
Pharma & Biotech
How Brazil’s GMP approval for pembrolizumab biosimilar changes global biosimilar dynamics
Blau Farmacêutica’s pembrolizumab biosimilar earns ANVISA GMP approval—see what this means for Brazil’s global position in cancer immunotherapy.